The usefulness of investigating the possible underlying conditions in rosacea

The usefulness of investigating the possible underlying conditions in rosacea EditorThe paper entitled ‘Rosacea and demodicidosis with gain of function mutation in STAT1’ by Second et al. is of indubitable interest and prompted us to make some observations. The Authors described a patient with cutaneous and ocular rosacea that they related to demodicidosis as oral ivermectin improved the cutaneous lesions. However, the Authors did not demonstrate by skin scraping nor by standardized skin surface biopsy (SSSB) an excessive number of Demodex folliculorum (DF) mites in the pilosebaceous units to justify an oral antiparasitic treatment as a drug of first choice. DF is usually found in the pilosebaceous follicle with an average density <5 mites/cm2, whereas its density may increase in the skin affected by rosacea. The Authors used 200 μg/kg ivermectin without indicating the daily dosage nor the treatment duration. Furthermore, it is not clear if the relatives of the proband, who shared the same STAT1 mutation and were diagnosed as having rosacea, have been treated with oral ivermectin and, in such case, if they improved as well. Lastly, the Authors did not specify the disease‐free time after ivermectin, although the follow‐up is important to establish the long‐term efficacy of the treatment, considering the frequent relapses observed after traditional http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of the European Academy of Dermatology & Venereology Wiley

The usefulness of investigating the possible underlying conditions in rosacea

Loading next page...
 
/lp/wiley/the-usefulness-of-investigating-the-possible-underlying-conditions-in-DcW2znWXhF
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 European Academy of Dermatology and Venereology
ISSN
0926-9959
eISSN
1468-3083
D.O.I.
10.1111/jdv.14547
Publisher site
See Article on Publisher Site

Abstract

EditorThe paper entitled ‘Rosacea and demodicidosis with gain of function mutation in STAT1’ by Second et al. is of indubitable interest and prompted us to make some observations. The Authors described a patient with cutaneous and ocular rosacea that they related to demodicidosis as oral ivermectin improved the cutaneous lesions. However, the Authors did not demonstrate by skin scraping nor by standardized skin surface biopsy (SSSB) an excessive number of Demodex folliculorum (DF) mites in the pilosebaceous units to justify an oral antiparasitic treatment as a drug of first choice. DF is usually found in the pilosebaceous follicle with an average density <5 mites/cm2, whereas its density may increase in the skin affected by rosacea. The Authors used 200 μg/kg ivermectin without indicating the daily dosage nor the treatment duration. Furthermore, it is not clear if the relatives of the proband, who shared the same STAT1 mutation and were diagnosed as having rosacea, have been treated with oral ivermectin and, in such case, if they improved as well. Lastly, the Authors did not specify the disease‐free time after ivermectin, although the follow‐up is important to establish the long‐term efficacy of the treatment, considering the frequent relapses observed after traditional

Journal

Journal of the European Academy of Dermatology & VenereologyWiley

Published: Jan 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial